The median survival rate of ibrutinib in the treatment of slow gonorrhea is about 8.5 years. As a selective TBK tyrosine kinase inhibitor, ibrutinib primarily inhibits the B-cell tumor survival…
The effect of taking ibrutinib for chronic lymphocytic leukemia varies from person to person, there is no specific data, it is recommended to take the drug under the guidance of…
There is no set period of time for how long ibrutinib should be taken before it can be discontinued, and patients who are eligible to take the drug will generally…
Date of approval: xxxx xx xx
Spelling: Yi Bu Ti Ni English name: ibrutinib Drug class: protein kinase inhibitor [otw_shortcode_tabslayout tabs=”8″ tab_1_title=”Overview” tab_1_content=”Ibrutinib is an antineoplastic drug. It has anti-sleeve cell lymphoma, chronic lymphocytic leukemia or…